Mulheres com câncer de mama: aspectos relacionados a recidiva e sobrevida

• Autor(a) principal: Peres, Valéria Costa
• Data de Publicação: 2014
• Tipo de documento: Dissertação
• Idioma: por
• Título da fonte: Repositório Institucional da UFG
• dARK ID: ark:/38995/0013000007n01
• Texto Completo: http://repositorio.bc.ufg.br/tede/handle/tede/4505
• topic: Neoplasias da mama; Recidiva; Sobrevida; Perda de seguimento; Enfermagem oncológica; Breast neoplasms; Recurrence; Survivorship; Lost to follow-up; Oncology nursing; CIENCIAS DA SAUDE::ENFERMAGEM

INTRODUCTION: Breast cancer is the leading cause of women’s death in many countries and the cancer type of highest incidence among Brazilian women. It is important to strengthen public health policies for women's health through multidisciplinary teamwork to identify the best interventions aiming early detection of the disease recurrence and suiting follow-up after the treatment has begun. OBJECTIVE: To evaluate the association between relapse and survival of women with breast cancer staging and follow-up for five years after diagnosis. METHODOLOGY: retrospective cross-sectional study made in a specialized cancer institute in the state of Goiás. The study population consisted of 460 records of women diagnosed with breast cancer in 2008 and treated in this institution. Data collection was conducted in the period of June and October of 2013 through semi-structured script prepared by the researcher and validated by an expertise of the area. The data were transferred to an excel spreadsheet and analyzed in Statistical Package for Social Science (SPSS) 19.0. Categorical variables were presented as absolute value (f) and percentage value (%) and continuous variables were presented as average ± standard deviation. Fisher’s exact test was used to verify the association among categorical variables. It was considered statistically significant if p <0.05. The Kaplan Meier estimator was also used to identify the survival of women in a period of five years. The project was approved by the ethics research committee and complied with the ethical and legal aspects set out in Resolution No. 466 / 012. RESULTS: It was identified a rate of 14% of deaths, 6% of local/regional recurrence and 25% of metastatic within five years. It was pointed that 26% of women missed follow-up, from these, 45% were diagnosed at stage III, 35% had cancer recurrence and 77% of women did not have consultation with the nurse during the period. CONCLUSION: It is noticed an improvement in survival of women with breast cancer in five years, but there are still a significant number of women being diagnosed in advanced stages. Among women who lost follow-up, a considerable number of them were identified as relapsed before leaving the following, which confirms the need for effective strategies to ensure follow-up of these women in the health service during the recommended period.